mojeNovosti.com
"We are going to apply for market authorization very soon. Hopefully, if everything goes well, by end of this fiscal, we should be in the market," she told Reuters by telephone.
Biocon's consolidated net profit rose 12.5 percent 788 million rupees during the fiscal first quarter ended June, it said.
(Reporting by Kaustubh Kulkarni)
Copyright 2013 mojeNovosti.com
web developer: BTGcms
